Fidelity Investments
VERV

Fidelity Investments’s Verve Therapeutics VERV Stock Holding History

Fidelity Investments’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,015
Closed -$90K – 5590
2025
Q2 		$90K Sell
8,015
-1,412,976
-99% -$8.05M ﹤0.01% 3653
2025
Q1 		$6.49M Buy
1,420,991
+4,226
+0.3% +$28.3K ﹤0.01% 2062
2024
Q4 		$7.99M Sell
1,416,765
-2,228
-0.2% -$12.6K ﹤0.01% 2014
2024
Q3 		$6.87M Buy
1,418,993
+3,873
+0.3% +$22.5K ﹤0.01% 2045
2024
Q2 		$6.91M Sell
1,415,120
-1,962,354
-58% -$12.3M ﹤0.01% 1980
2024
Q1 		$44.9M Sell
3,377,474
-67,096
-2% -$890K ﹤0.01% 1368
2023
Q4 		$48M Sell
3,444,570
-3,132,992
-48% -$38.8M ﹤0.01% 1309
2023
Q3 		$87.2M Buy
6,577,562
+531,182
+9% +$8.55M 0.01% 1036
2023
Q2 		$113M Sell
6,046,380
-780,437
-11% -$13M 0.01% 933
2023
Q1 		$98.4M Sell
6,826,817
-78,606
-1% -$1.54M 0.01% 991
2022
Q4 		$134M Sell
6,905,423
-576,927
-8% -$15.3M 0.01% 851
2022
Q3 		$257M Buy
7,482,350
+2,166,571
+41% +$69.1M 0.03% 583
2022
Q2 		$81.2M Buy
5,315,779
+199,869
+4% +$3.1M 0.01% 1047
2022
Q1 		$117M Buy
5,115,910
+114,427
+2% +$3.27M 0.01% 1011
2021
Q4 		$184M Buy
5,001,483
+1,519,602
+44% +$63.8M 0.01% 835
2021
Q3 		$164M Buy
3,481,881
+32,087
+0.9% +$1.89M 0.01% 886
2021
Q2 		$208M Buy
+3,449,794
New +$143M 0.02% 813

Other funds holding VERV

GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Fidelity Investments's VERV Position: Q3 2025 in Review

Fidelity Investments sold out of Verve Therapeutics (VERV) in Q3 2025, closing a stake of 8,015 shares — an estimated $90K sold.

Fidelity Investments first reported a position in VERV in Q2 2021 and held it in 17 quarters. The position peaked at $257M in Q3 2022. 6 funds tracked by Wall St. Rank hold VERV as of Q3 2025.

  • Fidelity Investments reported no remaining Verve Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Fidelity Investments sold 8,015 Verve Therapeutics shares in Q3 2025, an estimated $90K.
  • Fidelity Investments first reported a position in Verve Therapeutics in Q2 2021 and held it in 17 quarters.
  • Fidelity Investments's Verve Therapeutics position peaked at $257M in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2025.

Based on Fidelity Investments's 13F filing for Q3 2025, filed 13 Nov 2025.